| Code | Description | Claims | Beneficiaries | Total Paid |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
10,674 |
9,110 |
$392K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,401 |
7,737 |
$251K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,353 |
7,751 |
$247K |
| 84443 |
Thyroid stimulating hormone (TSH) |
19,209 |
17,053 |
$183K |
| 80053 |
Comprehensive metabolic panel |
25,549 |
22,708 |
$146K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,424 |
1,254 |
$115K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,452 |
3,133 |
$94K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,892 |
1,716 |
$93K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13,927 |
12,568 |
$92K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
4,685 |
4,300 |
$83K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
19,308 |
17,368 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,809 |
16,676 |
$61K |
| 80061 |
Lipid panel |
21,911 |
19,452 |
$61K |
| 86480 |
|
2,113 |
1,931 |
$61K |
| 85027 |
|
15,267 |
13,634 |
$55K |
| 86803 |
|
5,022 |
4,272 |
$48K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,061 |
5,324 |
$39K |
| 87340 |
|
4,755 |
3,868 |
$37K |
| 87480 |
|
2,063 |
1,894 |
$35K |
| 87510 |
|
2,052 |
1,884 |
$35K |
| 82607 |
|
4,638 |
4,023 |
$33K |
| 83655 |
|
4,364 |
4,127 |
$30K |
| 86787 |
|
2,906 |
2,399 |
$26K |
| 87660 |
|
2,090 |
1,915 |
$24K |
| 84403 |
|
1,604 |
1,439 |
$23K |
| 87631 |
|
416 |
336 |
$22K |
| 86780 |
|
2,381 |
2,016 |
$20K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
825 |
766 |
$20K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
740 |
613 |
$19K |
| 87653 |
|
621 |
542 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,881 |
3,573 |
$18K |
| 84439 |
|
3,186 |
2,868 |
$17K |
| 83001 |
|
1,669 |
1,457 |
$17K |
| 86038 |
|
1,350 |
1,093 |
$16K |
| 82746 |
|
2,298 |
2,022 |
$16K |
| 84702 |
|
2,956 |
2,200 |
$16K |
| 86762 |
|
3,082 |
2,577 |
$15K |
| 86592 |
|
5,454 |
4,609 |
$14K |
| 86003 |
|
461 |
377 |
$14K |
| 82570 |
|
4,543 |
4,105 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
798 |
716 |
$12K |
| 82043 |
|
4,762 |
4,351 |
$12K |
| 86850 |
|
3,370 |
2,835 |
$11K |
| 87507 |
|
65 |
62 |
$11K |
| 81001 |
|
6,812 |
5,970 |
$11K |
| 87186 |
|
1,450 |
1,277 |
$10K |
| 84146 |
|
1,228 |
1,060 |
$9K |
| 86901 |
|
3,409 |
2,880 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
234 |
229 |
$9K |
| 82728 |
|
1,839 |
1,604 |
$8K |
| 84466 |
|
1,742 |
1,501 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
195 |
164 |
$8K |
| 83540 |
|
2,188 |
1,892 |
$8K |
| 82105 |
|
887 |
838 |
$8K |
| 82950 |
|
2,703 |
2,461 |
$7K |
| 83020 |
|
1,223 |
1,052 |
$7K |
| 86900 |
|
3,404 |
2,874 |
$7K |
| 83013 |
|
608 |
540 |
$6K |
| 86140 |
|
2,335 |
2,018 |
$6K |
| 82670 |
|
809 |
703 |
$5K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
612 |
551 |
$5K |
| 84153 |
|
504 |
461 |
$5K |
| 81003 |
|
3,904 |
3,303 |
$5K |
| 88142 |
|
1,263 |
972 |
$4K |
| 85610 |
|
1,687 |
1,356 |
$4K |
| 87081 |
|
978 |
886 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
131 |
119 |
$3K |
| 85652 |
|
2,068 |
1,731 |
$3K |
| 86593 |
|
1,016 |
842 |
$3K |
| 86431 |
|
552 |
481 |
$3K |
| 82247 |
|
594 |
404 |
$3K |
| 86769 |
|
54 |
50 |
$2K |
| 87070 |
|
370 |
339 |
$2K |
| 85018 |
|
1,473 |
1,398 |
$2K |
| 83735 |
|
563 |
474 |
$2K |
| 84402 |
|
130 |
120 |
$2K |
| 85014 |
|
1,433 |
1,367 |
$2K |
| 83550 |
|
262 |
248 |
$2K |
| 85651 |
|
423 |
380 |
$2K |
| 82785 |
|
394 |
307 |
$2K |
| 86376 |
|
346 |
299 |
$2K |
| 82248 |
|
670 |
468 |
$2K |
| 85730 |
|
474 |
393 |
$1K |
| 83002 |
|
251 |
217 |
$1K |
| 82550 |
|
408 |
330 |
$1K |
| 84436 |
|
360 |
339 |
$1K |
| 80050 |
General health panel |
31 |
17 |
$1K |
| 82951 |
|
141 |
131 |
$1K |
| 87077 |
|
604 |
572 |
$999.99 |
| 86200 |
|
162 |
133 |
$977.10 |
| 83021 |
|
83 |
81 |
$951.39 |
| 87205 |
|
517 |
432 |
$922.30 |
| 36415 |
Collection of venous blood by venipuncture |
1,982 |
1,796 |
$857.41 |
| 86235 |
|
24 |
15 |
$823.80 |
| 0352U |
|
278 |
236 |
$725.76 |
| 84481 |
|
87 |
86 |
$697.02 |
| 80076 |
|
167 |
154 |
$621.33 |
| 84550 |
|
284 |
255 |
$602.60 |
| 84480 |
|
122 |
111 |
$568.53 |
| 83970 |
|
30 |
29 |
$548.49 |
| 86706 |
|
76 |
76 |
$531.35 |
| 85007 |
|
134 |
127 |
$441.00 |
| 82627 |
|
94 |
90 |
$395.39 |
| 85660 |
|
89 |
84 |
$391.58 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
52 |
47 |
$334.64 |
| 80074 |
|
15 |
14 |
$299.53 |
| 86039 |
|
47 |
27 |
$252.84 |
| 82952 |
|
123 |
116 |
$249.79 |
| 82784 |
|
30 |
27 |
$216.54 |
| 81015 |
|
59 |
54 |
$143.52 |
| 82565 |
|
44 |
29 |
$83.25 |
| 83690 |
|
12 |
12 |
$78.48 |
| 86765 |
|
12 |
12 |
$63.24 |
| 86735 |
|
12 |
12 |
$59.94 |
| 87102 |
|
15 |
15 |
$51.90 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
15 |
14 |
$51.51 |
| 84156 |
|
14 |
12 |
$19.04 |